Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study
- PMID: 32078650
- PMCID: PMC7032690
- DOI: 10.1371/journal.pmed.1003052
Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study
Abstract
Background: There is very limited data on the time trend of diabetes incidence in Asia. Using population-level data, we report the secular trend of the incidence of type 1 and type 2 diabetes in Hong Kong between 2002 and 2015.
Methods and findings: The Hong Kong Diabetes Surveillance Database hosts clinical information on people with diabetes receiving care under the Hong Kong Hospital Authority, a statutory body that governs all public hospitals and clinics. Sex-specific incidence rates were standardised to the age structure of the World Health Organization population. Joinpoint regression analysis was used to describe incidence trends. A total of 562,022 cases of incident diabetes (type 1 diabetes [n = 2,426]: mean age at diagnosis is 32.5 years, 48.4% men; type 2 diabetes [n = 559,596]: mean age at diagnosis is 61.8 years, 51.9% men) were included. Among people aged <20 years, incidence of both type 1 and type 2 diabetes increased. For type 1 diabetes, the incidence increased from 3.5 (95% CI 2.2-4.9) to 5.3 (95% CI 3.4-7.1) per 100,000 person-years (average annual percentage change [AAPC] 3.6% [95% CI 0.2-7.1], p < 0.05) in boys and from 4.3 (95% CI 2.7-5.8) to 6.4 (95% CI 4.3-8.4) per 100,000 person-years (AAPC 4.7% [95% CI 1.7-7.7], p < 0.05] in girls; for type 2 diabetes, the incidence increased from 4.6 (95% CI 3.2-6.0) to 7.5 (95% CI 5.5-9.6) per 100,000 person-years (AAPC 5.9% [95% CI 3.4-8.5], p < 0.05) in boys and from 5.9 (95% CI 4.3-7.6) to 8.5 (95% CI 6.2-10.8) per 100,000 person-years (AAPC 4.8% [95% CI 2.7-7.0], p < 0.05) in girls. In people aged 20 to <40 years, incidence of type 1 diabetes remained stable, but incidence of type 2 diabetes increased over time from 75.4 (95% CI 70.1-80.7) to 110.8 (95% CI 104.1-117.5) per 100,000 person-years (AAPC 4.2% [95% CI 3.1-5.3], p < 0.05) in men and from 45.0 (95% CI 41.4-48.6) to 62.1 (95% CI 57.8-66.3) per 100,000 person-years (AAPC 3.3% [95% CI 2.3-4.2], p < 0.05) in women. In people aged 40 to <60 years, incidence of type 2 diabetes increased until 2011/2012 and then flattened. In people aged ≥60 years, incidence was stable in men and declined in women after 2011. No trend was identified in the incidence of type 1 diabetes in people aged ≥20 years. The present study is limited by its reliance on electronic medical records for identification of people with diabetes, which may result in incomplete capture of diabetes cases. The differentiation of type 1 and type 2 diabetes was based on an algorithm subject to potential misclassification.
Conclusions: There was an increase in incidence of type 2 diabetes in people aged <40 years and stabilisation in people aged ≥40 years. Incidence of type 1 diabetes continued to climb in people aged <20 years but remained constant in other age groups.
Conflict of interest statement
RCWM acknowledges receiving research support (outside of this work) from AstraZeneca, Bayer, Pfizer for conducting clinical trials and honoraria or consultancy fees from AstraZeneca and Boehringer Ingelheim, all of which has been donated to the Chinese University of Hong Kong to support diabetes research. RCWM is a member of the Editorial Board of PLoS Medicine. AOYL acknowledges receiving research support (outside of this work) from Boehringer Ingelheim, MSD, Sanofi, Amgen and travel grants from travel grant from AstraZeneca, Boehringer Ingelheim, MSD, Novartis, Novo Nordisk, Sanofi. JCNC and RCWM are cofounders of GemVCare, a diabetes genetic testing laboratory, which was established through support from the Technology Start-up Support Scheme for Universities (TSSSU) from the Hong Kong Government Innovation and Technology Commission (ITC).
Figures


Similar articles
-
Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study.Diabetologia. 2020 Apr;63(4):757-766. doi: 10.1007/s00125-019-05074-7. Epub 2020 Jan 16. Diabetologia. 2020. PMID: 31942668
-
Secular trends in rates of hospitalisation for lower extremity amputation and 1 year mortality in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study.Diabetologia. 2020 Dec;63(12):2689-2698. doi: 10.1007/s00125-020-05278-2. Epub 2020 Sep 24. Diabetologia. 2020. PMID: 32970166
-
Trends in diabetes-related complications in Hong Kong, 2001-2016: a retrospective cohort study.Cardiovasc Diabetol. 2020 May 12;19(1):60. doi: 10.1186/s12933-020-01039-y. Cardiovasc Diabetol. 2020. PMID: 32398003 Free PMC article.
-
["Constantly rising or peaks and plateaus?" Incidence of childhood type 1 diabetes in Hungary (1989-2009)].Orv Hetil. 2011 Oct 16;152(42):1692-7. doi: 10.1556/OH.2011.29210. Orv Hetil. 2011. PMID: 21979222 Review. Hungarian.
-
Changing landscape of diabetes in Asia - What are the unmet needs?J Diabetes Investig. 2024 Apr;15(4):402-409. doi: 10.1111/jdi.14150. Epub 2024 Jan 24. J Diabetes Investig. 2024. PMID: 38265148 Free PMC article. Review.
Cited by
-
Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling study.Lancet Reg Health West Pac. 2025 Jun 5;59:101585. doi: 10.1016/j.lanwpc.2025.101585. eCollection 2025 Jun. Lancet Reg Health West Pac. 2025. PMID: 40529815 Free PMC article.
-
Subclasses of Glucose Trajectories in Early Childhood Stratified the Risk of Abnormal Glucose Tolerance in Adolescence and Young Adulthood.Diabetes. 2025 Sep 1;74(9):1635-1642. doi: 10.2337/db25-0256. Diabetes. 2025. PMID: 40549505 Free PMC article.
-
Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis.PLoS Med. 2020 Oct 2;17(10):e1003367. doi: 10.1371/journal.pmed.1003367. eCollection 2020 Oct. PLoS Med. 2020. PMID: 33007052 Free PMC article.
-
Risk of diabetes mellitus among users of immune checkpoint inhibitors: A population-based cohort study.Cancer Med. 2023 Apr;12(7):8144-8153. doi: 10.1002/cam4.5616. Epub 2023 Jan 16. Cancer Med. 2023. PMID: 36647331 Free PMC article.
-
Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-Year trends in 0·9 million adults with Diabetes in Hong Kong (2002-2019).Lancet Reg Health West Pac. 2022 Jun 24;26:100509. doi: 10.1016/j.lanwpc.2022.100509. eCollection 2022 Sep. Lancet Reg Health West Pac. 2022. PMID: 35789825 Free PMC article.
References
-
- International Diabetes Federation. IDF Diabetes Atlas. 8th ed Brussels, Belgium: International Diabetes Federation; 2017.
-
- Census and Statistic Department. Thematic Household Survey Report No. 50. Hong Kong SAR: Census and Statistics Department; 2013 [cited 2019 Oct 18]. https://www.statistics.gov.hk/pub/B11302502013XXXXB0100.pdf
MeSH terms
LinkOut - more resources
Full Text Sources
Medical